Paid Clinical Trials in Georgia

Georgia has 2,193 paid clinical trials enrolling now across cities including Atlanta, Augusta and Decatur. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Georgia include Emory University Hospital and Winship Cancer Institute, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 16, 2026.

Filter results

Filter results

State

City

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

2,193 clinical trials

↓ Download CSV

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

for Hyperphosphatemia

19 locations incl. Huntsville

Sponsor: R1 Therapeutics

Sex: All·Age: 18+

Code: NCT06712654·Phase 2·Recruiting

Apply to this trial

Innovative Closed-loop Functional Electrical Stimulation Control System for Augmenting Post-stroke Gait

for Post-stroke Hemiparesis

1 location in Atlanta

Sponsor: Emory University

Sex: All·Age: 40 - 90

Code: NCT07189819·Not Yet Recruiting

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

for Left Ventricular Systolic Dysfunction

Drug: Finerenone

22 locations incl. Aurora

Sponsor: Bayer

Sex: All·Age: Up to 18

Code: NCT07192952·Phase 3·Recruiting

Apply to this trial

PREcision MEDicine In Achalasia (PREMEDIA) - Cohort

for Type III Achalasia

13 locations incl. Scottsdale

Sponsor: Northwestern University

Sex: All·Age: 18+

Code: NCT07293689·Recruiting

Apply to this trial

Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

for Chin Augmentation

8 locations incl. Westport

Sponsor: Galderma R&D

Sex: All·Age: 22+·Accepts healthy volunteers

Code: NCT07566286·Not Yet Recruiting

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

for Prostate Cancer

6 locations incl. San Diego

Sponsor: Blue Earth Diagnostics

Sex: Male·Age: 18+

Code: NCT07569926·Phase 4·Not Yet Recruiting

GAIP ASD Research Study

for Autism Spectrum Disorder

2 locations incl. Roswell

Sponsor: Greater Atlanta Integrative Pediatrics

Sex: All·Age: 3+

Code: NCT07622316·Phase 1·Recruiting

Apply to this trial

Revive Toric RWE Study

for Astigmatism

3 locations incl. Orange Park

Sponsor: Bausch & Lomb Incorporated

Sex: All·Age: 18+

Code: NCT06785194·Not Yet Recruiting

Role of Omega-DEK in Childhood Apraxia of Speech

for Childhood Apraxia of Speech

2 locations incl. Atlanta

Sponsor: Claudia R. Morris

Sex: All·Age: 2 - 6

Code: NCT07216001·Phase 2·Not Yet Recruiting

Comprehensive Toileting Program

for Encopresis

1 location in Atlanta

Sponsor: Emory University

Sex: All·Age: 5 - 12

Code: NCT07226739·Phase 4·Not Yet Recruiting

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

for Breast Neoplasms

25 locations incl. Birmingham

Sponsor: Eli Lilly and Company

Sex: Female·Age: 18+

Code: NCT07287098·Phase 2·Not Yet Recruiting

Improving Maternal and Child Health Through Point-of-care STI Testing

for Treponema Pallidum Infection

1 location in Atlanta

Sponsor: Emory University

Sex: Female·Age: All ages·Accepts healthy volunteers

Code: NCT07290439·Not Yet Recruiting

Linking Youth to Pre-Exposure Prophylaxis (PrEP) Services

for HIV

4 locations incl. San Francisco

Sponsor: Westat

Sex: All·Age: 13 - 24·Accepts healthy volunteers

Code: NCT07438041·Not Yet Recruiting

Safer Drinking Spaces Study

for Sexual Violence

3 locations incl. Gainesville

Sponsor: RTI International

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07527988·Not Yet Recruiting

ALTO-207 in Adults With Treatment-resistant Depression (TRD)

for Treatment-resistant Depression (TRD)

38 locations incl. Birmingham

Sponsor: Alto Neuroscience

Sex: All·Age: 18 - 75

Code: NCT07553637·Phase 2·Recruiting

Apply to this trial

The PREVENT Resilience Study

for Psychological Trauma

2 locations incl. Atlanta

Sponsor: Emory University

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07568145·Not Yet Recruiting

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

for Alzheimer Disease

Drug: Donanemab

52 locations incl. Phoenix

Sponsor: Eli Lilly and Company

Sex: All·Age: 55+

Code: NCT07602582·Phase 3·Not Yet Recruiting

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

for Pneumococcal Disease

58 locations incl. Birmingham

Sponsor: Pfizer

Sex: All·Age: 42 Days - 211 Days·Accepts healthy volunteers

Code: NCT07629440·Phase 3·Recruiting

Apply to this trial

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

for Atopic Dermatitis

33 locations incl. Birmingham

Sponsor: Apollo Therapeutics Ltd

Sex: All·Age: 18 - 65

Code: NCT07599813·Phase 2·Recruiting

Apply to this trial

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

for Head and Neck Squamous Cell Carcinoma

Drug: Cemiplimab

6 locations incl. Irvine

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06980038·Phase 2·Recruiting

Apply to this trial

Inspiring Seniors Towards Exercise Promotion - 2

for Old Age

1 location in Atlanta

Sponsor: Emory University

Sex: All·Age: 65+·Accepts healthy volunteers

Code: NCT07629739·Recruiting

Apply to this trial

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

for ER-Positive HER2-Negative Breast Cancer

Drug: Camizestrant

12 locations incl. Duarte

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT07647328·Phase 3·Not Yet Recruiting

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

for Pancreatic Cancer

1 location in Atlanta

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT07621718·Phase 3·Recruiting

Apply to this trial

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

for Myelodysplastic Syndrome

24 locations incl. Gilbert

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT07422480·Phase 3·Recruiting

Apply to this trial

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

for Obesity

Drug: Semaglutide

99 locations incl. Birmingham

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18+

Code: NCT07564414·Phase 3·Recruiting

Apply to this trial

A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)

for Chronic Graft-versus-host-disease

11 locations incl. Duarte

Sponsor: Incyte Corporation

Sex: All·Age: 2 - 17

Code: NCT07124078·Phase 2·Recruiting

Apply to this trial

AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

for Obesity

Drug: NNC0487-0111

10 locations incl. Hollywood

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18+

Code: NCT07400107·Phase 3·Not Yet Recruiting

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

for Large Cell Neuroendocrine Carcinoma

5 locations incl. Atlanta

Sponsor: Molecular Partners AG

Sex: All·Age: 18+

Code: NCT07278479·Phase 1, Phase 2·Recruiting

Apply to this trial

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

for Major Depressive Disorder

25 locations incl. Birmingham

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All·Age: 18 - 70

Code: NCT06705478·Phase 2·Recruiting

Apply to this trial

TDAP in Burn Patients (Group 2)

for Sepsis

3 locations incl. Tampa

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Sex: All·Age: 18 - 80

Code: NCT07223684·Not Yet Recruiting

Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robustness and Generalizability of Post-burn Sepsis Prediction With the Post-Burn Sepsis Digital Twin. Group 1

for Sepsis

3 locations incl. Tampa

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Sex: All·Age: 18 - 80

Code: NCT07249762·Not Yet Recruiting

Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation

for Liver Transplant

10 locations incl. San Francisco

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All·Age: 3 - 13

Code: NCT07549503·Phase 2·Recruiting

Apply to this trial

A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers

for Smoking

7 locations incl. Maitland

Sponsor: RAI Services Company

Sex: All·Age: 21 - 65·Accepts healthy volunteers

Code: NCT07598136·Recruiting

Apply to this trial

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

for Locally Advanced Pancreatic Adenocarcinoma

274 locations incl. Anchorage

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT06998940·Phase 3·Recruiting

Apply to this trial

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

for Type 2 Diabetes Mellitus

12 locations incl. Los Angeles

Sponsor: Insulet Corporation

Sex: All·Age: 14 - 75

Code: NCT07579702·Recruiting

Apply to this trial

Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

for Coronary Artery Disease

14 locations incl. Sacramento

Sponsor: Supira Medical

Sex: All·Age: 18 - 90

Code: NCT07296744·Recruiting

Apply to this trial

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

for Myeloproliferative Neoplasms

Drug: INCA036978

22 locations incl. Birmingham

Sponsor: Incyte Corporation

Sex: All·Age: 18+

Code: NCT07441694·Phase 1·Recruiting

Apply to this trial

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

for Cardiovascular Disease and Lipoprotein(a)

Drug: Pelacarsen

115 locations incl. Andalusia

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 100

Code: NCT07517263·Phase 3·Recruiting

Apply to this trial

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

for Obesity

Drug: NNC0487-0111

202 locations incl. Alexander City

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18+

Code: NCT07567001·Phase 3·Not Yet Recruiting

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

for Obesity or Overweight

39 locations incl. Pelham

Sponsor: Amgen

Sex: All·Age: 18 - 99

Code: NCT07575399·Phase 3·Recruiting

Apply to this trial